- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02223962
Effects of Physical Activity Counseling After an Exacerbation in COPD
The Effects of a Physical Activity Counseling Program Immediately After an Exacerbation in Patients With COPD.
Studieoversikt
Detaljert beskrivelse
After signing the informed consent, the patients will be randomized into a control group, receiving usual care, or the intervention group receiving real-time feedback and physical activity counseling.
Intervention: Physical activity counseling will be provided by 3 weekly telephone contacts based on the step count from the Fitbit Ultra. In agreement with the patient and based on the step counts a patients provided, a new goal for the next week was set. The goal was to strive for the highest possible level of physical activity during one month.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Leuven, Belgia, 3000
- University Hospital Leuven
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Signed Informed Consent
- Chronic Obstructive Lung Disease (Tiff<70%)
- Hospitalized because of exacerbation
- Capable of working with electronic devices
Exclusion Criteria:
- Orthopedic/Neurologic problems making it difficult to be active
- Participation in a rehabilitation program
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Physical activity
The fitbit Ultra was used to provide real-time feedback on physical activity.
An experienced physiotherapist contacted the subjects 3 times a week to receive information about the amount of steps from the previous days.
In agreement with the patient, a new goal for the coming weeks was set and patients were motivated to achieve their individual goal.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
|
Placebo komparator: Usual Care
During the hospital stay, the patients in the control group will be informed about the beneficial effects of being physically inactive.They will not receive feedback about their activities performed and will not be stimulated to become more active.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Improvement in physical activity
Tidsramme: 1 month
|
The Dynaport MoveMonitor, a valid device in patients with COPD, was used to accurately measure the level of physical activity.
The device was provided 3 times to the patients (baseline, after 2 weeks, after 1 month).
The amount of steps, measured by this device, was used as the outcome measure.
|
1 month
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Improvement in functional exercise capacity
Tidsramme: 1 month
|
Functional exercise capacity was measured by the six minutes walking distance test (6MWD; meter).
This measurement was performed at baseline and after 1 month.
|
1 month
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- S55086
- ML8991 (Annen identifikator: University Hospital Leuven)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .